麗人麗粧(605136.SH)2022年度預虧1.12億元至1.39億元
格隆匯2月2日丨麗人麗粧(605136.SH)公佈,公司預計2022年實現歸屬於上市公司股東的淨利潤為-13940.01萬元至-11221.71萬元,同比變動-52295.39萬元至-55013.69萬元;與上年同期相比,將出現虧損。
預計歸屬於上市公司股東的扣除非經常性損益的淨利潤為-18035.82萬元至-14518.84萬元,同比變動-50772.97萬元至-54289.95萬元。
2022年,全國部分省市尤其是公司所在的上海市出現了較為嚴重的疫情。自3月下旬至5月底,公司位於上海及周邊地區的倉儲物流不暢嚴重影響公司營收的實現。結合供應鏈運輸困難,為了保證消費者體驗,避免斷貨,公司加大備貨庫存力度,導致計提跌價準備變高。同時由於全國範圍內疫情反覆,消費者對化粧品的需求發生一定的變化,公司採取多種方式促銷,導致整體毛利率下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.